Patents by Inventor Jeremiah Oyer

Jeremiah Oyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240010976
    Abstract: Compositions and methods for stimulating ?? T cell expansion and cytotoxicity are described. Therapeutic compositions and methods using expanded and stimulated ?? T cells are described.
    Type: Application
    Filed: August 12, 2021
    Publication date: January 11, 2024
    Inventors: Alicja COPIK, Jeremiah OYER, Thomas DIEFFENTHALLER, Griff PARKS
  • Publication number: 20230321191
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Application
    Filed: March 8, 2023
    Publication date: October 12, 2023
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer
  • Publication number: 20230293585
    Abstract: Disclosed are compositions and methods for directing NK cells to the bone marrow through the use of PM21 particles.
    Type: Application
    Filed: May 24, 2023
    Publication date: September 21, 2023
    Inventors: Alicja COPIK, Jeremiah OYER, Nitin CHAKRAVARTI, Dean Anthony Lee
  • Patent number: 11696927
    Abstract: Disclosed are compositions and methods for directing NK cells to the bone marrow through the use of PM21 particles.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: July 11, 2023
    Assignees: University of Central Florida Research Foundation, Inc., Research Institute at Nationwide Children's Hospital
    Inventors: Alicja Copik, Jeremiah Oyer, Nitin Chakravarti, Dean Anthony Lee
  • Patent number: 11617781
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: April 4, 2023
    Assignee: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer
  • Patent number: 10874715
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: December 29, 2020
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer
  • Publication number: 20200237822
    Abstract: Compositions and methods for stimulating NK cell expansion and cytotoxicity are described. Therapeutic compositions and methods using expanded and stimulated NK cells are described.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 30, 2020
    Inventors: Alicja Copik, Griffith Parks, Jeremiah Oyer
  • Publication number: 20200138908
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Application
    Filed: November 4, 2019
    Publication date: May 7, 2020
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer
  • Publication number: 20200061115
    Abstract: Disclosed are compositions and methods for directing NK cells to the bone marrow through the use of PM21 particles.
    Type: Application
    Filed: February 28, 2018
    Publication date: February 27, 2020
    Inventors: Alicja COPIK, Jeremiah OYER, Nitin CHAKRAVARTI, Dean Anthony Lee
  • Patent number: 10463715
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: November 5, 2019
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer
  • Publication number: 20190117736
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Application
    Filed: September 21, 2018
    Publication date: April 25, 2019
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer
  • Publication number: 20170319659
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Application
    Filed: April 17, 2017
    Publication date: November 9, 2017
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer
  • Patent number: 9623082
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: April 18, 2017
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer
  • Publication number: 20150190471
    Abstract: The application provides new compositions and methods for stimulating the production of natural killer (NK) cells in a subject. NK cells can be selectively expanded with a combination of stimulating ligands. Methods and compositions for the administration of stimulatory ligands modified to self-insert into tumor cells, thereby stimulating an increase in the number of NK cells in proximity to a tumor, are also described.
    Type: Application
    Filed: June 28, 2013
    Publication date: July 9, 2015
    Inventors: Alicja Copik, Vijay Reddy, Jeremiah Oyer